The susceptibility of Pneumocystis carinii to artemisinin (qinghaosu) was determined in short-term primary culture. In untreated cultures, trophozoites increased an average of fivefold over 4 days. Inhibition of parasite growth in cultures treated with artemisinin at concentrations as low as 0.5 ,uM was seen. In contrast, artemisinin concentrations up to 100 ,uM had no effect on feeder layer cells. (2, 4, 9, 11, 15) . In addition, artemisinin and artemether have recently been shown to be active against other parasitic organisms, including Toxoplasma gondii and Schistosoma mansoni (12, 13). We report here that artemisinin is also active against P. carinii in vitro.
Growth, isolation, and cultivation of organisms. Male Sprague-Dawley rats (150 to 200 g; Taconic Farms, Germantown, N.Y.) were fed ad libitum and administered tetracycline in their drinking water (1 g/liter). Subcutaneous injections of cortisone acetate (25 mg) were given twice per week. After 4 to 6 weeks of injection, those rats which showed signs of sluggishness, rapid breathing, weight loss, and hair loss were utilized in this study.
The rats were sacrificed and their lungs were then quickly removed and kept at 4°C. Impression smears were made from the lungs and stained with toluidine blue (7) (Fig. 1) . The inhibitory effect of pentamidine was not seen on day 1 of culture (<26%) but was evident on days 2 and 3 of culture, when inhibitions by 63 and 79%, respectively, were seen. In contrast, the effect of 100 ,uM artemisinin was evident after 1 day (Fig. 2) , with growth inhibited by 63, 76, and 78% on days 1, 2, and 3, respectively.
Artemisinin at concentrations of 50 and 5 ,uM also completely inhibited the growth of P. carinii for 4 days, without affecting the feeder layer cells (Fig. 3) . No effect at an artemisinin concentration of 0.1 ,uM was observed, although artemisinin at 0.5 ,uM had an intermediate effect.
As controls, feeder layer cells were incubated for 4 days in the presence of 100, 50, 10, and 1 ,uM artemisinin but in the absence of parasites, under conditions identical to those used for parasite culture. No effect was observable by phase-contrast microscopy. Feeder layer cells from the 100 ,uM artemisinin control were also dislodged from the wells by trypsinization and found viable by trypan blue exclusion (>95%). Furthermore, 0.5% ethanol had no effect either on the feeder layer cells or on parasite growth over 4 days (data not shown).
Conclusion. Artemisinin, a potent antimalarial agent, in-ANTIMICROB. AGENTS CHEMOTHER. hibits the growth of P. carinii in culture at concentrations as low as 0.5 ,uM. In contrast, artemisinin has no effect on Mv 1 Lu feeder layer cells at a concentration of 100 ,uM, indicating that the drug is selectively toxic to the parasite. An artemisinin concentration of 0.5 ,uM caused a 55% inhibition of growth. This is similar to the concentration which inhibits T. gondii, 0.3 puM (12), but is considerably higher than the concentration which inhibits plasmodium growth, 20 nM (10) . Nevertheless, concentrations which inhibit growth of P. carinii in vitro are close to the levels achieved in patients treated with artemisinin. For example, the peak concentration in plasma is 0.4 puM in patients 8 to 12 h after administration of artemisinin suppositories and is 3.5 ,uM in patients after intramuscular artemether administration (14) .
In this study, we used a short-term in vitro culture system to assess the effects of artemisinin on P. carinii. Others have reported increases in the number of trophozoites for as long as 10 days, accompanied by a 2-to 10-fold increase in cell number (5) . Short-term cultures have also been used to demonstrate the antipneumocystis activities of trimetho- Artemisinin and its derivatives represent a promising new class of antiparasitic drugs which act as free-radical generators (10) . They are currently being used in the treatment of malaria in China (4, 9, 15), Burma (11), and Vietnam (2). The results presented here suggest that they are potentially useful in the treatment of P. carinii pneumonia.
